期刊文献+

CD146在卵巢上皮性癌及子宫内膜癌中的表达 被引量:5

Expression of CD146 in the epithelial ovarian cancer and endometrial cancer
原文传递
导出
摘要 目的检测细胞黏附分子CD146在卵巢上皮性癌及子宫内膜癌组织中的表达,并探讨其表达与临床参数的相关性。方法采用免疫组化方法检测CD146在卵巢上皮性肿瘤组织和子宫内膜组织中的表达。结果 CD146在卵巢上皮性癌组织阳性率高于卵巢良性上皮肿瘤,差异有统计学意义(P<0.05);在子宫内膜组织中随着良性、非典型增生、恶性的变化而升高,各组间差异均有统计学意义(P<0.05)。CD146的高表达与卵巢上皮性癌的组织学分化、FIGO分期显著相关(r值分别为0.272、0.268,P<0.05),与子宫内膜癌的组织学分化、FIGO分期及浸润深度也存在显著相关(r值分别为0.315、0.262、0.346,P<0.05)。结论 CD146的高表达与卵巢上皮性癌及子宫内膜癌的发生、发展及转移有关,有可能是其诊断、术后随诊及靶向治疗的潜力分子。 Objective To investigate the expressions of cell adhesion molecules CD146 in patients with epithelial ovarian cancer and endometrial cancer and the correlation with clinical parameters. Methods The expression of CD146 in 157 cases with epithelial ovarian cancer and endometrial cancer was detected by immunohistochemistry. Results CD146 expression in the epithelial ovarian cancer was significantly higher than benign ovarian epithelial,with the difference statistically significant( P〈0. 05);CD146 expression in endometrial cancer increased with the normal,atypical hyperplasia and malignant,and the differences among each group were statistically significant( P〈0. 05). The high expression of CD146 in the epithelial ovarian carcinoma was significantly associated with histopathological differentiation and FIGO staging( r = 0. 271,0. 268,P〈0. 05). It was also significantly associated with histopathological differentitation,FIGO staging and depth of invasion in endometrial cancer( r = 0. 315,0. 262,0. 346,P〈0. 05). Conclusion The high expression of CD146 is associated with the occurrence,progression and metastasis of epithelial ovarian cancer and endometrial cancer. It may be used as a potential marker for diagnosis,postoperative follow- up and targeted therapy.
出处 《中国卫生检验杂志》 CAS 2016年第8期1069-1071,1075,共4页 Chinese Journal of Health Laboratory Technology
基金 河南省医学科技攻关计划项目(201403124) 2015年度河南省医学科技攻关计划普通项目(201503134)
关键词 CD146 卵巢上皮性癌 子宫内膜癌 免疫组化 CD146 Epithelial ovarian cancer Endometrial cancer Immunohistochemistry
  • 相关文献

参考文献18

  • 1Lehmann M, Holzmann B, Breitbart E, et al. Discrimination be- tween benign and malignant cells of melanocytic lineage by Two no- vel antigens, a glycoprotein with a molecular weight of 113000 and a protein with a molecular weight of76000[J]. Cancer Res, 1987, 47(3) : 841 -845.
  • 2Rapanotti MC, Ricozzi I, Campione E, et al. Blood MUC - 18/ MCAM expression in patients with melanoma: a suitable marker of poor outcome [ J ]. Br J Derrtology, 2013, 169 ( 1 ) : 221 - 222.
  • 3Zigler M, Villares GJ, Dobroff AS, et al. Expression of Id - 1 is Regulated by MCAM/MUC18: A Missing Link in Melanoma Pro- gression[J]. Cancer Res, 2011,71(10): 3494-3504.
  • 4Thomann S, Longerich T, Bazhin AV, et al. Selective targeting of liver cancer with the endothelial marker CD146 [ J ]. Oncotarget, 2014, 5(18) : 8614 -8624.
  • 5Oka S, Uramoto H, Chikaishi Y, et al. The Expression of CD146 predicts a poor overall survival in patients with adenocarcinoma of the lung[J]. Anticancer Res, 2012, 32(3) : 861 -864.
  • 6Elmageed ZY, Moroz K, Kandi E. Clinical significance of CD146 and latexin during different stages of thyroid cancer[ J]. Mol Cell Biochem, 2013, 381 (1/2) : 95 - 103.
  • 7Wu GJ, Wu MW, Wang SW, et aI. Isolation and characterization of the major form of human MUCI8 cDNA gene and correlation of MUC18 over - expression in prostate cancer cell lines and tissues with malignant progression [ J ]. Gene, 2001,279 ( 1 ) : 17 - 31.
  • 8Quhtit A, Ganr RL, Abd Elmageed ZY, et al. Towards under- standing the mode of action of the multifaceted cell adhesion recep- tor CD146[ J ]. Biochim Biophys Acta, 2009, 1795 (2): 130 - 136.
  • 9Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[ J]. CA- A Cancer J Clinicians, 2010, 60(5): 277-300.
  • 10Gagnon A, Ye B. Discovery and application of protein biomarkers for ovarian cancer[J]. Curr Opin Obstet Gynecol, 2008, 20( 1 ) : 9 -13.

二级参考文献13

  • 1李丽萍,杨春,曹骥,欧超,段小娴,李瑗,苏建家,岳惠芬,赵荫农.CD146 mRNA在人肝细胞癌组织中的表达及其临床意义[J].现代肿瘤医学,2006,14(12):1567-1570. 被引量:3
  • 2丁道芳,谢启文,刘述舜.医学科学研究基本方法[M].大连:辽宁科学技术出版社,1998:261.
  • 3Sadanandam A, Pal S N, Ziskovsky J, et al. MCAM: A database to accelerate the identification of functional cell adhesion molecules [J].Cancer Inform, 2008,6:47-50.
  • 4Leslie M C, Zhao Y J, Laehman L B, et al. hnmunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis[J]. Gene Ther, 2007,14 (4) :316- 323.
  • 5Liu J W, Nagpal J K, Jeronimo C, et al. Hypermethylation of MCAM gene is associated with advanced tumor stage in prostate cancer [ J ]. Prostate, 2008,68 (4) : 418-426.
  • 6Kristiansen G, Yu Y, SchlunsK, et al. Expression of the cell adhesion molecule CDI46/MCAM in non-small cell lung cancer [ J ]. Anal Cell Pathol, 2003,25 (2) : 77-81.
  • 7Zabouo G, lmbert A M, Jaequemier J, et al. CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines [J]. Breast Cancer Res, 2009, 11 ( 1 ) :R1.
  • 8Aldovini D, Demichelis F, Doglioni C, et al. M-CAM expression as marker of poor prognosis in epithelial ovarian cancer [ J ]. Int J Cancer, 2006,119 ( 8 ) : 1920-1926.
  • 9Lehmann J M, Riethmuller G, Johnson J P. MUC18, a marker of tumor progression in human melanoma, shows sequence similarityto the neural cell adhesion molecules of the immuno-globulin superfamily [Jl. Proc Natl Acad Sci USA, 1989,86 (24) : 9891-9895.
  • 10Shih I M. The role of CD146 (MeI-CAM) in biology and pathology [ J ]. J Pathol, 1999,89 ( 1 ) : 4-11.

共引文献3

同被引文献40

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部